Lipocine Inc. (LPCN)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| |
| Total insider Buys/Sells last 6 months: |
| Transactions | Total |
| Buys |
0 |
$0 |
| Sells |
0 |
$0 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
Open Market Insider Buys
| Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
| 25 May 2023 |
PATEL MAHESH V. |
CEO and President |
25 May 2023 |
8,706 |
5.03 |
43,791 |
| 24 Mar 2023 |
PATEL MAHESH V. |
CEO and President |
24 Mar 2023 |
150,000 |
0.32 |
48,000 |
| 20 Mar 2023 |
ONO RICHARD DANA |
Director |
20 Mar 2023 |
4,000 |
0.34 |
1,360 |
| 17 Mar 2023 |
PATEL MAHESH V. |
CEO and President |
17 Mar 2023 |
50,000 |
0.33 |
16,500 |
| 28 Nov 2022 |
PAPAPETROPOULOS SPYROS |
Director |
22 Nov 2022 |
21,739 |
0.47 |
10,217 |
| 14 Nov 2022 |
PATEL MAHESH V. |
CEO and President |
14 Nov 2022 |
75,000 |
0.39 |
29,250 |
| 27 Sep 2022 |
PATEL MAHESH V. |
CEO and President |
27 Sep 2022 |
100,000 |
0.41 |
41,000 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock